| AstraZeneca and Bristol-Myers Squibb expand Onglyza labelling - Zenopa |
|
|
Zenopa The drug has been approved by the European Commission for the treatment of adult type 2 diabetes patients suffering from moderate or severe renal impairment, making it the first therapy of its kind to be ratified for this group. ... EU approves Onglyza diabetes drug for kidney cases BusinessWeek EU approves label update for Onglyza to treat type 2 diabetes patients with |